Millennium Management’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
Millennium Management's EIKN Position: Q2 2026 in Review
Millennium Management reduced its Eikon Therapeutics (EIKN) stake by 24% in Q2 2026, selling an estimated $435K and leaving 133,020 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #3926.
Millennium Management first reported a position in EIKN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.86M in Q1 2026. 77 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.
- Millennium Management held 133,020 shares of Eikon Therapeutics worth $1.74M as of Q2 2026.
- Millennium Management sold 42,607 Eikon Therapeutics shares in Q2 2026, an estimated $435K.
- Eikon Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #3926 holding.
- Millennium Management first reported a position in Eikon Therapeutics in Q1 2026 and has held it in 2 quarters since.
- Millennium Management's Eikon Therapeutics position peaked at $1.86M in Q1 2026.
- 77 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.